Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2.
about
Interaction of nectin-like molecule 2 with integrin alpha6beta4 and inhibition of disassembly of integrin alpha6beta4 from hemidesmosomesCADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity.CADM1 controls actin cytoskeleton assembly and regulates extracellular matrix adhesion in human mast cellsRedundant Postsynaptic Functions of SynCAMs 1-3 during Synapse Formation.Engagement of overexpressed Her2 with GEP100 induces autonomous invasive activities and provides a biomarker for metastases of lung adenocarcinoma.Genetic variants in Cell Adhesion Molecule 1 (CADM1): a validation study of a novel endothelial cell venous thrombosis risk factor.Cell adhesion molecules nectins and associating proteins: Implications for physiology and pathologyA global microRNA screen identifies regulators of the ErbB receptor signaling network.PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinaseHuman T-cell leukemia virus type 1 (HTLV-1) tax requires CADM1/TSLC1 for inactivation of the NF-κB inhibitor A20 and constitutive NF-κB signaling.The Cell Adhesion Molecule Necl-4/CADM4 Serves as a Novel Regulator for Contact Inhibition of Cell Movement and Proliferation.CADM1 isoforms differentially regulate human mast cell survival and homotypic adhesion.A Novel Nectin-mediated Cell Adhesion Apparatus That Is Implicated in Prolactin Receptor Signaling for Mammary Gland Development.Reduction of the ST6 β-galactosamide α-2,6-sialyltransferase 1 (ST6GAL1)-catalyzed sialylation of nectin-like molecule 2/cell adhesion molecule 1 and enhancement of ErbB2/ErbB3 signaling by microRNA-199a.Genetic deletion of Cadm4 results in myelin abnormalities resembling Charcot-Marie-Tooth neuropathy.PTPN13/PTPL1: an important regulator of tumor aggressiveness.Integrated Proteomic and Genomic Analysis of Gastric Cancer Patient Tissues.Tumour-suppressive role of PTPN13 in hepatocellular carcinoma and its clinical significance.Suppression of the TGF-β1-induced protein expression of SNAI1 and N-cadherin by miR-199a.Aberrations of a cell adhesion molecule CADM4 in renal clear cell carcinoma.Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer.Nectin-like molecule-4/cell adhesion molecule 4 inhibits the ligand-induced dimerization of ErbB3 with ErbB2.Interaction of Necl-4/CADM4 with ErbB3 and integrin α6 β4 and inhibition of ErbB2/ErbB3 signaling and hemidesmosome disassembly.miR-214 and hypoxia down-regulate Necl-2/CADM1 and enhance ErbB2/ErbB3 signaling.Eutopic endometrium and peritoneal, ovarian and colorectal endometriotic tissues express a different profile of nectin-1, -3, -4 and nectin-like molecule 2.Aging-dependent expression of synapse-related proteins in the mouse brain.Regulatory role of the cell adhesion molecule nectin-1 in GABAergic inhibitory synaptic transmission in the CA3 region of mouse hippocampus.Investigation of the role of DNA methylation in the expression of ERBB2 in human myocardium.Nectin-4 co-stimulates the prolactin receptor by interacting with SOCS1 and inhibiting its activity on the JAK2-STAT5a signaling pathway.Cadm3 (Necl-1) interferes with the activation of the PI3 kinase/Akt signaling cascade and inhibits Schwann cell myelination in vitro.CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation.
P2860
Q24336974-74FEE020-FED0-420A-9ED1-A284607DB811Q27323547-F4BBF932-FB81-460C-AAD6-6F6A6D18CDE0Q27332182-804785B6-8D7C-4852-822A-55D52FA3CAE9Q30363319-E5CA3240-5DAC-4284-B531-41DFEF344568Q34038203-7C2276AD-C962-4FD1-94A6-7BF096884D5BQ34616494-1B0768DB-C1EB-44DD-9A32-E8D6233B3C84Q34838804-3D23DDD5-2ADF-44EE-8267-11E9591ED118Q35041481-F77F5D97-5DEC-4754-A524-571A3F8F429FQ35094072-45E04A30-48A7-46F5-82AE-711F2DE73DF5Q35182251-BC8764E1-38EA-4034-BD19-38889913A301Q35609836-D5C82047-CA37-4882-B333-89AEB2F2144CQ36103727-35140C28-DBC4-4359-8992-3696DED5C28BQ36674694-59C21FC3-EC95-43DC-ACF9-477098F7F809Q36796821-DDE09019-D7F2-495F-B5A8-A4C803BD9CB8Q37032402-3B3AA1AD-0761-4AE2-9CA1-6666A76572E0Q37828546-2FCD2797-2E01-4A0E-9766-4123B5D8FA0CQ38402575-D2D7D62A-B060-45A3-9924-E5A4079D48D6Q38800302-7186C12C-F640-4B0B-A9FE-D34D36F7B9E5Q38973907-FF58A20C-AD8A-406D-9535-DEDB57279FBEQ39547646-8BC41959-7B20-46F5-BF61-E6BB95D20B0CQ39551556-558D8994-B3C6-412D-8EAD-A0F0712A627DQ41196669-9119B46B-C31E-4BA0-BFF5-A9776658D676Q44666075-D721F721-E926-4AE4-9325-4EBD53C51B7AQ46209823-DB7E8F33-3277-4FB5-8BE0-A0046AC4B150Q47215933-B6A7ECB0-82A8-41D3-AEE6-DAD6DCCE47A6Q47833656-D0963916-47BB-4310-85B6-86A4AA0E3DA0Q49154833-0A8B94BD-1253-4D26-B149-42F8011A5216Q50875570-BC9B446D-8E12-444A-AB51-4C10C256FC72Q51112517-2D4A8D0B-23B7-4282-A903-2F8FBC3BA7B2Q51474265-54C0CE8F-B227-44CB-B9AA-9860575851C0Q52308826-A8424FB7-1165-49A8-A4D0-2A84667DC799
P2860
Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2.
@en
Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2.
@nl
type
label
Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2.
@en
Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2.
@nl
prefLabel
Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2.
@en
Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2.
@nl
P2093
P2860
P356
P1476
Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2.
@en
P2093
Hisakazu Ogita
Megumi Kishimoto
Satoshi Kawano
Wataru Ikeda
Yoshimi Takai
P2860
P304
23793-23805
P356
10.1074/JBC.M109.025155
P407
P577
2009-06-26T00:00:00Z